Tradestie Institutional Equity Comparison Engine
PRE vs PMI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PMI Overall Edge
PMI Captures Institutional Edge (3โ1 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Picard Medical, Inc. (PMI) driven by superior Valuation, Momentum & Technical, Options & Structure while PRE counters with relative strength in Growth & Margin. Fundamentally, PRE trades at N/M Forward P/E with -32.5% operating margin (+172.2% YoY revenue) versus PMI at N/M Forward P/E and -248.1% operating margin (+38.6% YoY). In options structure, PRE sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro) against PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PMI
PRE N/M vs PMI N/M Fwd P/E
Growth & Margin Winner
PRE
Op Margin -32.5% vs -248.1% ยท YoY +172.2% vs +38.6%
Momentum & Technical Winner
PMI
1Y -16.3% vs +107.2% ยท 52W Pos 6% vs 34%
Options & Structure Winner
PMI
BREAKDOWN (13th %ile IV) vs UNCLASSIFIED (N/A IV)
PRE
NASDAQ
Prenetics Global Limited Class A Ordinary Share
Laboratory Analytical Instruments
$10.31
-0.39% 1D
Market Cap
$205.5M
1M Return
-38.37%
1Y Return
-16.28%
Forward P/E
N/M
Unified AI Score
40.8 / 100
SELL
Tech 25.0
Fund 45.0
Flow 55.0
Mom 44.0
PMI
NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap
$17.1M
1M Return
-34.58%
1Y Return
+107.24%
Forward P/E
N/M
Unified AI Score
48.4 / 100
HOLD
Tech 39.0
Fund 45.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PRE -16.28%
PMI +107.24%
Spread: +164.31 pp (PMI Lead)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | PRE Revenue | PMI Revenue | PRE Op. Margin | PMI Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q2 '25 | $50M | $10M | -70.0% | -165.2% | PRE |
| Q3 '25 | $90M | $0M | -27.8% | -293.8% | PRE |
| Q4 '25 | $150M | $0M | -35.9% | -297.6% | PRE |
| Q1 '26 | $140M | $0M | -27.0% | -392.3% | PRE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PRE | PMI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $205.5M | $17.1M | Larger Scale | PRE |
| Trailing P/E Ratio Valuation | N/M | 2.9x | Lower Multiple | PMI |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +172.2% | +38.6% | Higher Growth | PRE |
| Operating Margin (TTM) Profitability | -32.5% | -248.1% | Higher Margin | PRE |
| Net Profit Margin Profitability | -32.6% | 0.0% | Higher Margin | PMI |
| Return on Equity (ROE) Capital Efficiency | -67.8% | 0.0% | Higher ROE | PMI |
| 52-Week Range Position Momentum | 6% ($9โ$27) | 34% ($0โ$18) | Stronger Trend | PMI |
| Beta / 30D Volatility Risk Regime | 1.66ฮฒ ยท 141% Vol | 54.06ฮฒ ยท 134% Vol | Lower Realized Risk | PMI |
| Unified Institutional Score Composite Signal | 40.8 / 100 (SELL) | 48.4 / 100 (HOLD) | Higher Composite | PMI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PRE vs PMI Buy Guide
PRE
BREAKDOWN
59d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
13th %ile
IV Regime
Compressed (<25th %ile)
PMI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PRE nor PMI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.